Analysis of the effect of the bovine adenosine triphosphate-binding cassette transporter G2 single nucleotide polymorphism Y581S on transcellular transport of veterinary drugs using new cell culture models

Journal of Animal Science

Volumn 89, Issue 12, 2011, Pages 4325-4338

  Real, R ^a   Gonzalez Lobato L ^a   Baro, M F ^a   Valbuena, S ^a   de la Fuente, A ^a   Prieto, J G ^a   Alvarez A I ^a   Marques, M M ^a   Merino, G ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

Breast cancer resistance protein (ABCG2 BCRP); Polymorphism; Transcellular transport; Veterinary antibiotic

Indexed keywords

ABC TRANSPORTER; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; IVERMECTIN; VETERINARY DRUG;

ACTIVE TRANSPORT; ANIMAL; ARTICLE; CATTLE; CELL LINE; CULTURE TECHNIQUE; DOG; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPARASITIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CATTLE; CELL CULTURE TECHNIQUES; CELL LINE; DOGS; GENE EXPRESSION REGULATION; IVERMECTIN; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; VETERINARY DRUGS;

EID: 82155192218     PISSN: 00218812     EISSN: 15253163     Source Type: Journal    
DOI: 10.2527/jas.2011-3841     Document Type: Article

References (47)

1. Allen, J. D., R. F. Brinkhuis, L. van Deemter, J. Wijnholds, and A. H. Schinkel. 2000. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Cancer Res. 60:5761-5766.
2. Allen, J. D., A. van Loevezijn, J. M. Lakhai, M. van der Valk, O. van Tellingen, G. Reid, J. H. Schellens, G. J. Koomen, and A. H. Schinkel. 2002. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1:417-425.
3. Bardsley, W. G. 2001. SIMFIT. Simulation, Fitting, Statistics and Plotting. Version 5.4. Reference Manual. University of Manchester, Manchester, UK.
4. Breedveld, P., J. H. Beijnen, and J. H. Schellens. 2006. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol. Sci. 27:17-24.
5. Cascorbi, I. 2006. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol. Ther. 112:457-473.
6. Cohen-Zinder, M., E. Seroussi, D. M. Larkin, J. J. Loor, A. Evertsvan der Wind, J. H. Lee, J. K. Drackley, M. R. Band, A. G. Hernandez, M. Shani, H. A. Lewin, J. I. Weller, and M. Ron. 2005. Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattle. Genome Res. 15:936-944.
7. Cusatis, G., and A. Sparreboom. 2008. Pharmacogenomic importance of ABCG2. Pharmacogenomics 9:1005-1009.
8. Hegedus, C., G. Szakács, L. Homolya, T. I. Orbán, A. Telbisz, M. Jani, and B. Sarkadi. 2009. Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays. Adv. Drug Deliv. Rev. 61:47-56.
9. Idowu, O. R., J. O. Peggins, R. Cullison, and J. Bredow. 2010. Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers after intravenous administration of enrofloxacin. Res. Vet. Sci. 89:230-235.
10. International Transporter Consortium, K. M. Giacomini, S. M. Huang, D. J. Tweedie, L. Z. Benet, K. L. Brouwer, X. Chu, A. Dahlin, R. Evers, V. Fischer, K. M. Hillgren, K. A. Hoffmaster, T. Ishikawa, D. Keppler, R. B. Kim, C. A. Lee, M. Niemi, J. W. Polli, Y. Sugiyama, P. W. Swaan, J. A. Ware, S. H. Wright, S. W. Yee, M. J. Zamek-Gliszczynski, and L. Zhang. 2010. Membrane transporters in drug development. Nat. Rev. Drug Discov. 9:215-236.
11. Ismail, M. 2007. Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves. Vet. Res. Commun. 31:467-476.
12. Jani, M., I. Makai, E. Kis, P. Szabó, T. Nagy, P. Krajcsi, and A. Lespine. 2011. Ivermectin interacts with human ABCG2. J. Pharm. Sci. 100:94-97.
13. Jonker, J. W., M. Buitelaar, E. Wagenaar, M. A. van der Valk, G. L. Scheffer, R. J. Scheper, T. Plosch, F. Kuipers, R. P. Elferink, H. Rosing, J. H. Beijnen, and A. H. Schinkel. 2002. The breast cancer resistance protein protects against a major chlorophyll derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99:15649-15654.
14. Jonker, J. W., G. Merino, S. Musters, A. E. van Herwaarden, E. Bolscher, E. Wagenaar, E. Mesman, T. C. Dale, and A. H. Schinkel. 2005. The Breast Cancer Resistance Protein (BCRP/ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 11:127-129.
15. Jonker, J. W., J. W. Smit, R. F. Brinkhuis, M. Maliepaard, J. H. Beijnen, J. H. Schellens, and A. H. Schinkel. 2000. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 92:1651-1656.
16. Keskitalo, J. E., O. Zolk, M. F. Fromm, K. J. Kurkinen, P. J. Neuvonen, and M. Niemi. 2009. ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. Clin. Pharmacol. Ther. 86:197-203.
17. Kinsella, T. M., and G. P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
18. Komisarek, J., and Z. Dorynek. 2009. Effect of ABCG2, PPARGC1A, OLR1 and SCD1 gene polymorphism on estimated breeding values for functional and production traits in Polish Holstein-Friesian bulls. J. Appl. Genet. 50:125-132. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19193979&dopt=Abstract
19. Marazuela, M. D., and M. C. Moreno-Bondi. 2004. Multiresidue determination of fluoroquinolones in milk by column liquid chromatography with fluorescence and ultraviolet absorbance detection. J. Chromatogr. A 1034:25-32.
20. McManaman, J. L., and M. C. Neville. 2003. Mammary physiology and milk secretion. Adv. Drug Deliv. Rev. 55:629-641.
21. Merino, G., A. I. Alvarez, M. M. Pulido, A. J. Molina, A. H. Schinkel, and J. G. Prieto. 2006. Breast Cancer Resistance Protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability pharmacokinetics and milk secretion. Drug Metab. Dispos. 34:690-695.
22. Merino, G., J. W. Jonker, E. Wagenaar, A. E. van Herwaarden, and A. H. Schinkel. 2005a. The Breast Cancer Resistance Protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion and milk secretion of the antibiotic nitrofurantoin. Mol. Pharmacol. 67:1758-1764.
23. Merino, G., R. Real, M. F. Baro, L. Gonzalez-Lobato, J. G. Prieto, A. I. Alvarez, and M. M. Marques. 2009. Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: Increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors. Drug Metab. Dispos. 37:5-9.
24. Merino, G., A. E. van Herwaarden, E. Wagenaar, J. W. Jonker, and A. H. Schinkel. 2005b. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol. Pharmacol. 67:1765-1771.
25. Mestorino, N., M. L. Marchetti, E. Turic, J. Pesoa, and J. Errecalde. 2009. Concentrations of danofloxacin 18% solution in plasma, milk and tissues after subcutaneous injection in dairy cows. Anal. Chim. Acta 637:33-39.
26. Michiels, F., R. A. van der Kammen, L. Janssen, G. Nolan, and J. G. Collard. 2000. Expression of Rho GTPases using retroviral vectors. Methods Enzymol. 325:295-302.
27. Michot, J. M., F. van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2004. Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter. Antimicrob. Agents Chemother. 48:2673-2682.
28. Muenster, U., B. Grieshop, K. Ickenroth, and M. J. Gnoth. 2008. Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions. Pharm. Res. 25:2320-2326.
29. Noguchi, K., K. Katayama, J. Mitsuhashi, and Y. Sugimoto. 2009. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv. Drug Deliv. Rev. 61:26-33.
30. Olsen, H. G., H. Nilsen, B. Hayes, P. R. Berg, M. Svendsen, S. Lien, and T. Meuwissen. 2007. Genetic support for a quantitative trait nucleotide in the ABCG2 gene affecting milk composition of dairy cattle. BMC Genet. 8:32.
31. Ozvegy, C., A. Váradi, and B. Sarkadi. 2002. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation. J. Biol. Chem. 277:47980-47990.
32. Pavek, P., G. Merino, E. Wagenaar, E. Bolscher, M. Novotna, J. W. Jonker, and A. H. Schinkel. 2005. Human breast cancer resistance protein: Interactions with steroid drugs, hormones,the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J. Pharmacol. Exp. Ther. 312:144-152.
33. Pérez, M., R. Real, G. Mendoza, G. Merino, J. G. Prieto, and A. I. Alvarez. 2009. Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: Modulation by isoflavones. J. Vet. Pharmacol. Ther. 32:498-502.
34. Pulido, M. M., A. J. Molina, G. Merino, J. G. Prieto, and A. I. Álvarez. 2006. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): Influence of flavonoids and role in milk secretion in sheep. J. Vet. Pharmacol. Ther. 29:279-287.
35. Ramirez, C. J., J. D. Minch, J. M. Gay, S. M. Lahmers, D. J. Guerra, G. J. Haldorson, T. Schneider, and K. L. Mealey. 2011. Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats. Pharmacogenet. Genomics 21:66-75.
36. Real, R., E. Egido, M. Pérez, L. González-Lobato, B. Barrera, J. G. Prieto, A. I. Alvarez, and G. Merino. 2011. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: Interaction with ivermectin. J. Vet. Pharmacol. Ther. 34:313-321.
37. Robey, R. W., P. A. Fetsch, O. Polgar, M. Dean, and S. E. Bates. 2006. The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2. Res. Vet. Sci. 81:345-349.
38. Ron, M., M. Cohen-Zinder, C. Peter, J. I. Weller, and G. Erhardt. 2006. Short communication: A polymorphism in ABCG2 in Bos indicus and Bos taurus cattle breeds. J. Dairy Sci. 89:4921-4923.
39. Sissung, T. M., C. E. Baum, C. T. Kirkland, R. Gao, E. R. Gardner, and W. D. Figg. 2010. Pharmacogenetics of membrane transporters: An update on current approaches. Mol. Biotechnol. 44:152-167.
40. Tamura, A., Y. Onishi, R. An, S. Koshiba, K. Wakabayashi, K. Hoshijima, W. Priebe, T. Yoshida, S. Kometani, T. Matsubara, K. Mikuriya, and T. Ishikawa. 2007. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. Drug Metab. Pharmacokinet. 22:428-440.
41. Tantia, M. S., R. K. Vijh, B. P. Mishra, B. Mishra, S. T. Kumar, and M. Sodhi. 2006. DGAT1 and ABCG2 polymorphism in Indian cattle (Bos indicus) and buffalo (Bubalus bubalis) breeds. BMC Vet. Res. 2:32.
42. van Herwaarden, A. E., E. Wagenaar, G. Merino, J. W. Jonker, H. Rosing, J. H. Beijnen, and A. H. Schinkel. 2007. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol. Cell. Biol. 27:1247-1253.
43. Vethanayagam, R. R., H. Wang, A. Gupta, Y. Zhang, F. Lewis, J. D. Unadkat, and Q. Mao. 2005. Functional analysis of the human variants of breast cancer resistance protein: I206L, N590Y, and D620N. Drug Metab. Dispos. 33:697-705.
44. Woodward, O. M., A. Köttgen, J. Coresh, E. Boerwinkle, W. B. Guggino, and M. Köttgen. 2009. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl. Acad. Sci. USA 106:10338-10342.
45. Wu, H. J., J. Luo, N. Wu, K. Matand, L. J. Zhang, X. F. Han, and B. J. Yang. 2008. Cloning, sequence and functional analysis of goat ATP-binding cassette transporter G2 (ABCG2). Mol. Biotechnol. 39:21-27.
46. Yue, W., K. Abe, and K. L. Brouwer. 2009. Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: A novel tool to assess the contribution of Bcrp to drug iliary excretion. Mol. Pharm. 6:134-143.
47. Zamber, C. P., J. K. Lamba, K. Yasuda, J. Farnum, K. Thummel, J. D. Schuetz, and E. G. Schuetz. 2003. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 13:19-28.